Central American economies suffer from storms, climate shock -Moodys

whalebeings.com
Joel Elconin is the co-host of Benzingas #PreMarket Prep , a daily trading idea radio show. Gilead Sciences, Inc. (NASDAQ: GILD ) shares were trading higher by $3.81 at $104.32 in Fridays session. The catalyst for the rally is a Q1 beat for EPS ($2.94 vs. $2.32 estimates) and revenue ($7.59 billion vs. $6.92 billion estimates). In addition, the company boosted guidance for the remainder of the year. The company now expects net product sales of $28 billion to $29 billion, versus its prior forecast of $26 billion to $27 billion. Related Link: Morgan Stanley On What Should Be Rewarded At Gilead After a higher open ($103.20 vs. Thursdays close of $100.51), it retreated to $102.50 before resuming its rally. So far, it has breached the pair just below the $104 level, reaching $104.27. If the rally continues, there may be additional resistance at Mondays high ($104.53) and additional resistance at the series of highs at the $105.50 level from late April. See more from Benzinga Tweet, Rumor And Bernstein Fueling Rallies In Gilead Sciences, Vertex Pharmaceuticals Gilead Sciences Hovering Above Major Support Level Gilead Shares Reacting To Death Of Patient © 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. View comments
Smartflower: A Stylish Solution for Sustainable Off-the-Grid Living
Discover the Smartflower, a unique solar solution that combines style and efficiency for off-the-grid living.